VISICORT researchers at NUI Galway exhibited at the Galway Science and Technology Forum on 26 November 2017. In excess of 20,000 people attended the exhibition day. The NUI Galway regenerative medicine stand was the brainchild of Dr Siobhán Gaughan who works across several EU-funded stem cell projects coordinated at NUI Galway. Coordinators Matt Griffin and […]
Author Archive for: visicort_admin
This author has yet to write their bio.Meanwhile lets just say that we are proud visicort_admin contributed a whooping 57 entries.
Entries by visicort_admin
The 7th annual BioBanking conference on took place on the 14th and 15th of June 2017 in Central London, UK. The meeting brought together Europe’s leading biorepositories, regulatory representatives and scientific pioneers to strengthen knowledge in biosample management and explore future advances in areas such as mobile bio-banking and cloud-based sample management. Understanding the ethical and […]
The 115th Deutsche Ophthalmologishe Gesellschaft (DOG) conference was held in Berlin from 28 September – 1 October 2017. Here, Prof Uwe Pleyer of Charité Universitätsmedizin Berlin co-chaired the ‘Germany goes to Europe: European Research Consortia with German participation’ session. VISICORT was presented by Prof Pleyer during this session which highlighted five projects funded by the European Commission. […]
Dr Malcolm Walkinshaw, of SynthSys, Edinburgh joins the VISICORT project. Dr Walkinshaw obtained his PhD in physical chemistry at Edinburgh University. After post-doc positions in Purdue and Gottingen he joined the Swiss company Sandoz (now Novartis) where he built and led a successful 25 person strong ‘Drug Discovery Group’ which made important contributions to understanding […]
Matt Griffin has been Professor of Transplant Biology in NUI Galway’s School of Medicine and a Consultant Nephrologist at Galway University Hospitals since July 2008. He qualified in Medicine from University College Cork in 1988 and trained in General Medicine and Nephrology in Cork, Dublin and Mayo Clinic Rochester, USA between 1989 and 1997. He […]
Pranali Sanghvi, a student at the Regenerative Medicine Institute (REMEDI) at NUI Galway presented her work entitled, ‘Investigating the effects of different MSC therapies on immune cell infiltrates in allogeneic corneal transplants’ at the Regenerative Medicine Research Symposium held in the Biosciences Building at NUI Galway on 18 August 2017. Pranali’s project was supervised by […]
Does it help your fitness to have an event as a goal when you are training? Can cartoons and comics help children to achieve better results in tests? How would you even find out? Dr Siobhán Gaughan, NUI Galway Programmme Manager of ADIPOA-2, VISICORT and AUTOSTEM was on hand at the awards ceremony for a […]
Hosted by Leiden University Medical Center, the EU MSC2 2017 meeting in Leiden, NL on September 12th and 13th will assemble twelve EU-funded, mesenchymal stromal cell-focussed consortia. Projects to be presented include: REDDSTAR, REACH, RETHRIM, Stellar, MERLIN, Nephstrom, SCIENCE, VISICORT and Adipoa-2, AUTOSTEM, BOOSTB4, SEPCELL, RESSTORE, and RESPINE. This two day, interactive meeting will be held at the Stadsgehoorzaal Leiden. Three overarching aspects of the EU-MSC2 meeting include: mechanisms of action and […]
Biostór Ireland’s Peadar Mac Gabhann presented the VISICORT Biorepository at the 7th International Biobanking Summit in London on Thursday, June 15, 2017.
VISICORT researcher Dr Paul Lohan presented his work on MSC cell therapy in high risk cornea transplantation at the Regenerative Medicine Institute (REMEDI) seminar which took place in the Biomedical Sciences Building NUI Galway on Thursday 8th June. The seminar was attended by research scientists and principal investigators.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602470. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.